Crossmark

Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer

Crossref DOI link: https://doi.org/10.1186/s13014-021-01925-z

Published Online: 2021-10-12

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Luo, He-San

Chen, Ying-Ying

Huang, Wei-Zhen

Wu, Sheng-Xi

Huang, Shao-Fu

Xu, Hong-Yao

Xue, Ren-Liang

Du, Ze-Sen

Li, Xu-Yuan

Lin, Lian-Xin

Huang, He-Cheng
License Information

Text and Data Mining valid from 2021-10-12

Version of Record valid from 2021-10-12
More Information

Article History

Received: 2 June 2021

Accepted: 24 September 2021

First Online: 12 October 2021

Declarations

:

: Not applicable.

: Not applicable.

: Authors declare that there is no conflict of interest.

: The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Document is current

Any future updates will be listed below